Zeichner, Joshua, M.D. Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT01448733
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now